z-logo
open-access-imgOpen Access
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
Author(s) -
Felix Y. Feng,
Huei–Chung Huang,
Daniel E. Spratt,
Shuang G. Zhao,
Howard M. Sandler,
Jeffry Simko,
Elai Davicioni,
Paul L. Nguyen,
Alan Pollack,
Jason A. Efstathiou,
Adam P. Dicker,
Tamara R. Todorović,
Jennifer Margrave,
Yang Liu,
Bashar Dabbas,
Darby J. S. Thompson,
Rajdeep Das,
James J. Dignam,
Christopher Sweeney,
Gerhardt Attard,
Jean-Paul Bahary,
Himanshu Lukka,
William A. Hall,
Thomas M. Pisansky,
Amit B. Shah,
Stephanie L. Pugh,
William U. Shipley,
Phuoc T. Tran
Publication year - 2021
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2020.7671
Subject(s) - medicine , interquartile range , prostate cancer , randomized controlled trial , prostatectomy , clinical endpoint , context (archaeology) , oncology , cancer , paleontology , biology
Decipher (Decipher Biosciences Inc) is a genomic classifier (GC) developed to estimate the risk of distant metastasis (DM) after radical prostatectomy (RP) in patients with prostate cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom